Drug recall
Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced
FDA recall event 92032 · Class II · Stanford Blood Center
Key facts
| Event ID | 92032 |
|---|---|
| Recall numbers | B-0328-2023 |
| Recalling firm | Stanford Blood Center |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced Apheresis Platelets, Pathogen Reduced, which were inadequately illuminated due to a loss of power, were distributed. |
| Initiation date | Jan 19, 2023 |
| Report date | Apr 19, 2023 |
| Termination date | Apr 13, 2023 |
| City | Palo Alto |
| State | CA |
| Country | United States |
| FEI number | 2970004 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: